Airway immune homeostasis and implications for influenza-induced inflammation

Trends in Immunology

Volumn 32, Issue 7, 2011, Pages 328-334

  Snelgrove, Robert J ^a   Godlee, Alexandra ^a   Hussell, Tracy ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CATHELICIDIN; DEFENSIN; INTERLEUKIN 10; NITRIC OXIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE INHIBITOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TOLL LIKE RECEPTOR AGONIST; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; AIRWAY; ANTIGEN PRESENTING CELL; BACTERIAL SUPERINFECTION; CELL POPULATION; ENDOTHELIUM CELL; FIBROBLAST; HAEMOPHILUS INFLUENZAE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFECTION; INFLAMMATION; INFLUENZA; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PLASMACYTOID DENDRITIC CELL; RESPIRATORY EPITHELIUM; RESPIRATORY SYSTEM; REVIEW; STAPHYLOCOCCUS AUREUS; STIMULUS RESPONSE; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; VIRUS; VIRUS INFECTION;

ANIMALS; HOMEOSTASIS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA;

EID: 79959800238     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.04.006     Document Type: Review

References (90)

1. Holt P.G., et al. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 2008, 8:142-152.
2. Guth A.M., et al. Lung environment determines unique phenotype of alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296:L936-L946.
3. Maus U.A., et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am. J. Respir. Cell Mol. Biol. 2006, 35:227-235.
4. Wands J.M., et al. Distribution and leukocyte contacts of gammadelta T cells in the lung. J. Leukoc. Biol. 2005, 78:1086-1096.
5. Looney M.R., et al. Stabilized imaging of immune surveillance in the mouse lung. Nat. Methods 2011, 8:91-96.
6. Jahnsen F.L., et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J. Immunol. 2006, 177:5861-5867.
7. Khoor A., et al. Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. J. Histochem. Cytochem. 1993, 41:1311-1319.
8. Watford W.T., et al. Surfactant protein A regulates complement activation. J. Immunol. 2001, 167:6593-6600.
9. Yamada C., et al. Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response, Importance of supratrimeric oligomerization. J. Biol. Chem. 2006, 281:21771-21780.
10. Sano H., et al. Regulation of inflammation and bacterial clearance by lung collectins. Respirology 2006, 11(Suppl.):S46-S50.
11. Sano H., et al. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J. Immunol. 1999, 163:387-395.
12. Janssen W.J., et al. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am. J. Respir. Crit. Care Med. 2008, 178:158-167.
13. Haczku A. Protective role of the lung collectins surfactant protein. A and surfactant protein D in airway inflammation. J. Allergy Clin. Immunol. 2008, 122:861-879.
14. Takabayshi K., et al. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 2006, 24:475-487.
15. Munger J.S., et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328.
16. Morris D.G., et al. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature (London) 2003, 422:169-173.
17. Ueno K., et al. MUC1 mucin is a negative regulator of toll-like receptor signaling. Am. J. Respir. Cell Mol. Biol. 2008, 38:263-268.
18. Barclay A.N., et al. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 2002, 23:285-290.
19. Minas K., Liversidge J. Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?. Crit. Rev. Immunol. 2006, 26:213-230.
20. Snelgrove R.J., et al. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat. Immunol. 2008, 9:1074-1083.
21. Rygiel T.P., et al. Lack of CD200 enhances pathological T cell responses during influenza infection. J. Immunol. 2009, 183:1990-1996.
22. Ramadas R.A., et al. Surfactant protein A enhances production of secretory leukoprotease inhibitor and protects it from cleavage by matrix metalloproteinases. J. Immunol. 2009, 182:1560-1567.
23. Sallenave J.M. Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity. Am. J. Respir. Cell Mol. Biol. 2010, 42:635-643.
24. Jia H.P., et al. Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L428-L437.
25. Akbari O., et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 2002, 8:1024-1032.
26. de Heer H.J., et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 2004, 200:89-98.
27. Holt P.G., et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 1993, 177:397-407.
28. Akbari O., et al. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001, 2:725-731.
29. Bedoret D., et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J. Clin. Invest. 2009, 119:3723-3738.
30. Thepen T., et al. Regulation of immune response to inhaled antigen by alveolar macrophages: differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs. immunity. Eur. J. Immunol. 1991, 21:2845-2850.
31. Bleck B., et al. Diesel exhaust particle-exposed human bronchial epithelial cells induce dendritic cell maturation. J. Immunol. 2006, 176:7431-7437.
32. Bilyk N., Holt P.G. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1993, 177:1773-1777.
33. Mayer A.K., et al. Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment. Eur. J. Immunol. 2008, 38:1689-1699.
34. Wang H., et al. Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation. Thorax 2009, 64:283-290.
35. Ward C., et al. Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells. Thorax 2009, 64:430-435.
36. Steinmuller C., et al. Local activation of nonspecific defense against a respiratory model infection by application of interferon-gamma: comparison between rat alveolar and interstitial lung macrophages. Am. J. Respir. Cell Mol. Biol. 2000, 22:481-490.
37. Roth M.D., Golub S.H. Human pulmonary macrophages utilize prostaglandins and transforming growth factor beta 1 to suppress lymphocyte activation. J. Leukoc. Biol. 1993, 53:366-371.
38. Chelen C.J., et al. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J. Clin. Invest. 1995, 95:1415-1421.
39. Balbo P., et al. Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma. Clin. Exp. Allergy 2001, 31:625-636.
40. Malur A., et al. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response. J. Immunol. 2009, 182:5816-5822.
41. Gereke M., et al. Alveolar type II epithelial cells present antigen to CD4(+) T cells and induce Foxp3(+) regulatory T cells. Am. J. Respir. Crit Care Med. 2009, 179:344-355.
42. Corbiere V., et al. Phenotypic characteristics of human type II alveolar epithelial cells suitable for antigen presentation to T lymphocytes. Respir. Res. 2011, 12:15.
43. Borchers M.T., et al. The role of T cells in the regulation of acrolein-induced pulmonary inflammation and epithelial-cell pathology. Res. Rep. Health Eff. Inst. 2009, 5-29.
44. Kirby A.C., et al. Pulmonary dendritic cells and alveolar macrophages are regulated by gammadelta T cells during the resolution of S. pneumoniae-induced inflammation. J. Pathol. 2007, 212:29-37.
45. Rehan V.K., et al. Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 299:L672-L680.
46. Vancheri C., et al. Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells. Respir. Res. 2005, 6:103.
47. Weppler A., Issekutz A.C. Alveolar epithelium down-modulates endotoxin-but not tumor necrosis factor alpha-induced activation of endothelium and selectively inhibits neutrophil transendothelial migration. Exp. Lung Res. 2008, 34:425-453.
48. Jiang-Shieh Y.F., et al. Distribution and expression of CD200 in the rat respiratory system under normal and endotoxin-induced pathological conditions. J. Anat. 2010, 216:407-416.
49. Bedke T., et al. Endothelial cells augment the suppressive function of CD4+CD25+Foxp3+regulatory T cells: involvement of programmed death-1 and IL-10. J. Immunol. 2010, 184:5562-5570.
50. Hussell T., Goulding J. Structured regulation of inflammation during respiratory viral infection. Lancet Infect. Dis. 2010, 10:360-366.
51. Herold S., et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 2008, 205:3065-3077.
52. Guillot L., et al. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J. Biol. Chem. 2004, 279:2712-2718.
53. Liang J., et al. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J. Immunol. 2007, 178:2469-2475.
54. Fernandez S., et al. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. J. Immunol. 2004, 172:2613-2620.
55. Homma T., et al. Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. Am. J. Respir. Cell Mol. Biol. 2004, 31:463-469.
56. Bilyk N., Holt P.G. Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations. Immunology 1995, 86:231-237.
57. Lohmann-Matthes M.L., et al. Pulmonary macrophages. Eur. Respir. J. 1994, 7:1678-1689.
58. Tate M.D., et al. Neutrophils sustain effective CD8(+) T-cell responses in the respiratory tract following influenza infection. Immunol. Cell Biol. 2011, 10.1038/icb. 2011.26.
59. Narasaraju T., et al. MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. Am. J. Respir. Cell Mol. Biol. 2010, 42:732-743.
60. Dahl M.E., et al. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat. Immunol. 2004, 5:337-343.
61. Beyer M., et al. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J. Allergy Clin. Immunol. 2004, 113:127-133.
62. van der Sluijs K.F., et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J. Immunol. 2004, 172:7603-7609.
63. Piersma S.J., et al. Influenza matrix 1-specific human CD4+ FOXP3+ and FOXP3(-) regulatory T cells can be detected long after viral clearance. Eur. J. Immunol. 2010, 40:3064-3074.
64. Raftogiannis M., et al. Indication for a role of regulatory T cells for the advent of influenza A (H1N1)-related pneumonia. Clin. Exp. Immunol. 2010, 161:576-583.
65. Antunes I., Kassiotis G. Suppression of innate immune pathology by regulatory T cells during influenza A virus infection of immunodeficient mice. J. Virol. 2010, 84:12564-12575.
66. GeurtsvanKessel C.H., et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 2009, 206:2339-2349.
67. Zhang F., et al. A soluble thymic stromal lymphopoietin (TSLP) antagonist. TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells. Clin. Exp. Immunol. 2011, 164:256-264.
68. Horvath K.M., et al. Epithelial cells from smokers modify dendritic cell responses in the context of influenza infection. Am. J. Respir. Cell Mol. Biol. 2010, 10.1165/rcmb.2010-0190OC.
69. Didierlaurent A., et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 2008, 205:323-329.
70. Morens D.M., et al. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 2008, 198:962-970.
71. Iverson A.R., et al. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J. Infect. Dis. 2011, 10.1093/infdis/jiq113.
72. Ballinger M.N., Standiford T.J. Postinfluenza bacterial pneumonia: host defenses gone awry. J. Interferon Cytokine Res. 2010, 30:643-652.
73. Hartshorn K.L., et al. Neutrophil deactivation by influenza A virus Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J. Immunol. 1995, 154:3952-3960.
74. Abramson J.S., Mills E.L. Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev. Infect. Dis. 1988, 10:326-341.
75. Engelich G., et al. Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: role of respiratory burst. J. Leukoc. Biol. 2001, 69:50-56.
76. Colamussi M.L., et al. Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood 1999, 93:2395-2403.
77. McNamee L.A., Harmsen A.G. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect. Immun. 2006, 74:6707-6721.
78. Shahangian A., et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 2009, 119:1910-1920.
79. Sun K., Metzger D.W. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat. Med. 2008, 14:558-564.
80. Fadok V.A., et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta PGE2, and PAF. J. Clin. Invest 1998, 101:890-898.
81. Voll R.E., et al. Immunosuppressive effects of apoptotic cells. Nature (London) 1997, 390:350-351.
82. Medeiros A.I., et al. Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J. Exp. Med. 2009, 206:61-68.
83. Small C.L., et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J. Immunol. 2010, 184:2048-2056.
84. Kudva A., et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J. Immunol. 2011, 186:1666-1674.
85. Weeks J.N., et al. Combined immunotherapy with intravenous immune globulin and P4 peptide rescues mice from post-influenza pneumococcal pneumonia. Antimicrob. Agents Chemother. 2011, 10.1128/AAC.00057-11.
86. McDonald P.P., et al. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells. J. Immunol. 1999, 163:6164-6172.
87. Huynh M.L., et al. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 2002, 109:41-50.
88. Serezani C.H., et al. Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 2007, 37:562-570.
89. De S.C., et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 2008, 118:4036-4048.
90. Deshane J., et al. Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness. Mucosal. Immunol. 2011, 10.1038/mi.2011.16.